Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
N Engl J Med ; 369(20): 1904-14, 2013 Nov 14.
Article in English | MEDLINE | ID: mdl-24224623

ABSTRACT

BACKGROUND: Human prion diseases, although variable in clinicopathological phenotype, generally present as neurologic or neuropsychiatric conditions associated with rapid multifocal central nervous system degeneration that is usually dominated by dementia and cerebellar ataxia. Approximately 15% of cases of recognized prion disease are inherited and associated with coding mutations in the gene encoding prion protein (PRNP). The availability of genetic diagnosis has led to a progressive broadening of the recognized spectrum of disease. METHODS: We used longitudinal clinical assessments over a period of 20 years at one hospital combined with genealogical, neuropsychological, neurophysiological, neuroimaging, pathological, molecular genetic, and biochemical studies, as well as studies of animal transmission, to characterize a novel prion disease in a large British kindred. We studied 6 of 11 affected family members in detail, along with autopsy or biopsy samples obtained from 5 family members. RESULTS: We identified a PRNP Y163X truncation mutation and describe a distinct and consistent phenotype of chronic diarrhea with autonomic failure and a length-dependent axonal, predominantly sensory, peripheral polyneuropathy with an onset in early adulthood. Cognitive decline and seizures occurred when the patients were in their 40s or 50s. The deposition of prion protein amyloid was seen throughout peripheral organs, including the bowel and peripheral nerves. Neuropathological examination during end-stage disease showed the deposition of prion protein in the form of frequent cortical amyloid plaques, cerebral amyloid angiopathy, and tauopathy. A unique pattern of abnormal prion protein fragments was seen in brain tissue. Transmission studies in laboratory mice were negative. CONCLUSIONS: Abnormal forms of prion protein that were found in multiple peripheral tissues were associated with diarrhea, autonomic failure, and neuropathy. (Funded by the U.K. Medical Research Council and others.).


Subject(s)
Autonomic Nervous System Diseases/etiology , Brain/pathology , Diarrhea/etiology , Prion Diseases/genetics , Prions/genetics , Animals , Autonomic Nervous System Diseases/pathology , Female , Humans , Longitudinal Studies , Male , Mice , Mice, Transgenic , Mutation , Pedigree , Phenotype , Plaque, Amyloid/pathology , Prion Diseases/complications , Prion Diseases/pathology , Prion Diseases/transmission , Prion Proteins
2.
Mov Disord ; 25(15): 2508-15, 2010 Nov 15.
Article in English | MEDLINE | ID: mdl-20818670

ABSTRACT

The lower brain stem of 25 pathologically-confirmed Parkinson's disease (PD) cases was examined by alpha synuclein immunohistochemistry to characterize pathological accumulation of alpha synuclein (Lewy-type α-synucleinopathy, LTS) in the medulla oblongata, to examine differences between affected regions and test a proposed model of staging of pathology in PD. All cases had LTS in the medulla, including the dorsal motor nucleus of the vagus (dmX), when present. The distribution followed a consistent pattern and appeared to be concentrated in a tyrosine hydroxylase (TH) immunoreactive region, probably representing the dorsal IX/X nuclear complex and the intermediate reticular zone. LTS density was greatest in the dmX. A similar distribution pattern to PD was seen in 14 incidental Lewy body disease (ILBD) cases, five derived from the Queen Square Brain Bank tissue collection and nine identified in separate series of 60 neurologically-normal individuals, and in three cases with the G2019S mutation of LRRK2. Semiquantitative assessment showed that severity of pathology in the dmX was not correlated with the severity of cortical pathology. Semiquantitative assay of TH and ChAT peptide expression in the medulla showed that TH expression in PD and ILBD did not differ from controls. These findings broadly support the Braak hypothesis of caudo-rostral development but indicate that the extent of the disease in the cortex and the severity of pathology in the medulla were independent of one another.


Subject(s)
Brain Stem/pathology , Neurons/pathology , Parkinson Disease/pathology , Aged , Brain Stem/metabolism , Female , Humans , Immunohistochemistry , Lewy Bodies/metabolism , Lewy Bodies/pathology , Lewy Body Disease/pathology , Male , Middle Aged , Neurons/metabolism , Odds Ratio , Parkinson Disease/metabolism , Severity of Illness Index , Tyrosine 3-Monooxygenase/metabolism , alpha-Synuclein/metabolism
3.
Mov Disord ; 25(5): 570-7, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20209627

ABSTRACT

Previous studies suggested that olfaction is normal in progressive supranuclear palsy (PSP). We applied the University of Pennsylvania Smell Identification Test (UPSIT) to 36 patients with PSP who scored more than 18 on the Mini Mental State Examination (MMSE), 140 patients with nondemented Parkinson's disease (PD) and 126 controls. Mean UPSIT scores in PSP were lower than in controls (P < 0.001) but higher than in PD (P < 0.001) after adjusting for age, gender, and smoking history. For patients with PSP, UPSIT scores correlated with MMSE (r = 0.44, P = 0.006) but not disease duration (P = 0.6), motor subscale of the Unified Parkinson's Disease Rating Scale (P = 0.2), or Frontal Assessment Battery (P = 0.5). The brains of six of the patients with PSP were examined postmortem and all revealed neurofibrillary tangles and tau accumulation in the rhinencephalon, although only three had hyposmia. Further prospective studies including patients with early PSP and PSP-P with postmortem confirmation might help clarify if smell tests could be useful when the differential diagnosis lies between PD and PSP.


Subject(s)
Olfaction Disorders/etiology , Smell/physiology , Supranuclear Palsy, Progressive/complications , Adult , Aged , Aged, 80 and over , Case-Control Studies , Humans , Male , Mental Status Schedule , Middle Aged , Nerve Degeneration/etiology , Nerve Degeneration/pathology , Olfactory Pathways/pathology , Olfactory Pathways/physiopathology , ROC Curve , Retrospective Studies
4.
Neurosci Lett ; 453(2): 77-80, 2009 Apr 03.
Article in English | MEDLINE | ID: mdl-19356597

ABSTRACT

We studied alpha-synuclein pathology in the rhinencephalon of ten cases of Parkinson's disease (PD) and twelve neurologically normal controls, of which seven had incidental Lewy bodies in the substantia nigra at autopsy and five had no pathological evidence of neurological disease. In all PD and incidental Lewy bodies cases, alpha-synuclein pathology was found in all five subregions of the primary olfactory cortex that were sampled, and amongst them the pathology was significantly more severe in the temporal division of the piriform cortex than in the frontal division of the piriform cortex, olfactory tubercle or anterior portions of the entorhinal cortex. The orbitofrontal cortex, which is an area of projection from the primary olfactory cortex, was affected in some cases but overall the alpha-synuclein pathology was less severe in this area than in the primary olfactory cortex. Because different areas of the rhinencephalon are likely to play different roles in olfaction and our data indicate a differential involvement by alpha-synuclein deposition of structures implicated in smell, future prospective studies investigating the pathophysiological basis of hyposmia in PD should consider to examine the areas of primary olfactory cortex separately.


Subject(s)
Lewy Body Disease/pathology , Olfactory Pathways/chemistry , Parkinson Disease/pathology , alpha-Synuclein/analysis , Analysis of Variance , Autopsy , Entorhinal Cortex/chemistry , Frontal Lobe/chemistry , Humans , Immunohistochemistry , Substantia Nigra/chemistry
5.
J Neuropathol Exp Neurol ; 61(3): 254-67, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11895040

ABSTRACT

Familial Danish dementia (FDD) is pathologically characterized by widespread cerebral amyloid angiopathy (CAA), parenchymal protein deposits, and neurofibrillary degeneration. FDD is associated with a mutation of the BRI2 gene located on chromosome 13. In FDD there is a decamer duplication, which abolishes the normal stop codon, resulting in an extended precursor protein and the release of an amyloidogenic fragment, ADan. The aim of this study was to describe the major neuropathological changes in FDD and to assess the distribution of ADan lesions, neurofibrillary pathology, glial, and microglial response using conventional techniques, immunohistochemistry, confocal microscopy, and immunoelectron microscopy. We showed that ADan is widely distributed in the central nervous system (CNS) in the leptomeninges, blood vessels, and parenchyma. A predominance of parenchymal pre-amyloid (non-fibrillary) lesions was found. Abeta was also present in a proportion of both vascular and parenchymal lesions. There was severe neurofibrillary pathology, and tau immunoblotting revealed a triplet electrophoretic migration pattern comparable with PHF-tau. FDD is a novel form of CNS amyloidosis with extensive neurofibrillary degeneration occurring with parenchymal, predominantly pre-amyloid rather than amyloid, deposition. These findings support the notion that parenchymal amyloid fibril formation is not a prerequisite for the development of neurofibrillary tangles. The significance of concurrent ADan and Abeta deposition in FDD is under further investigation.


Subject(s)
Amyloid beta-Peptides/metabolism , Amyloidosis/metabolism , Brain Diseases/metabolism , Dementia/genetics , Dementia/metabolism , Adult , Amyloidosis/pathology , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Benzothiazoles , Blood Vessels/metabolism , Brain Diseases/pathology , Coloring Agents , Congo Red , Dementia/pathology , Denmark , Female , Fluorescent Dyes , Glial Fibrillary Acidic Protein/metabolism , Histocompatibility Antigens Class II/metabolism , Humans , Immunoblotting , Immunohistochemistry , Male , Microscopy, Electron , Microscopy, Immunoelectron , Middle Aged , Pedigree , Staining and Labeling , Thiazoles , tau Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...